Page last updated: 2024-09-05

lasofoxifene and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

lasofoxifene has been researched along with 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol in 1 studies

Compound Research Comparison

Studies (lasofoxifene)	Trials (lasofoxifene)	Recent Studies (post-2010) (lasofoxifene)	Studies (1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol)	Trials (1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol)	Recent Studies (post-2010) (1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol)
88	14	24	343	5	66

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kumar, P; Song, ZH	1

Other Studies

1 other study(ies) available for lasofoxifene and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

Article	Year
CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene. Biochemical and biophysical research communications, 2014, Jan-03, Volume: 443, Issue:1 Topics: Benzoxazines; Cyclic AMP; Dronabinol; Drug Inverse Agonism; HEK293 Cells; Humans; Indoles; Morpholines; Naphthalenes; Pyrrolidines; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes	2014

Article

Year

CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene.

Biochemical and biophysical research communications, 2014, Jan-03, Volume: 443, Issue:1

Topics: Benzoxazines; Cyclic AMP; Dronabinol; Drug Inverse Agonism; HEK293 Cells; Humans; Indoles; Morpholines; Naphthalenes; Pyrrolidines; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes

2014